Table 2.
Clinical features of patients with autoimmune thyroid disease (AITD) from whom RT-PCR was performed.
| AITD | HT | GD | GO | p-value |
|---|---|---|---|---|
| n | 13 | 13 | 13 | |
| Gender (F/M) | 12/1 | 12/1 | 12/1 | |
| Age (year) | 49.7 ± 15.9 | 43.2 ± 16.4 | 38.9 ± 9.9 | 0.1704 (one way ANOVA) |
| TSH mU/mL | 1.97 (0.84–2.72) | 0.3 (0.01–1.38) | 0.4 (0.01–1.76) | 0.0527 (Kruskal–Wallis test) |
| T4 ng/dL | 1.22 (1.04–1.41) | 1.49 (1.02–2.27) | 1.12 (0.96–1.23) | 0.3692 (Kruskal–Wallis test) |
| Tg-Ab UI/mL | 334 (180–412) | 360 (344–1134) | 643.5 (20–1483) | 0.4569 (Kruskal–Wallis test) |
| TPO-Ab UI/mL | 306 (150–724.5) | 125.5 (61.6–2235) | 354 (101–812) | 0.6506 (Kruskal–Wallis test) |
| TSHR-Ab U/L | – | 3.8 (1.82–28.9) | 2.4 (1.4–5.63) | 0.4313 (Mann–Whitney test) |
Values show number for categorical values and median (interquartile intervals 25–75) for continuous variables. HT = Hashimoto's thyroiditis; GD = Graves’ disease; GO=Graves'Ophthalmopathy. F/M = female/male; TSH, thyrotropin (Normal range = 0.27–4.20); T4, thyroxine (Normal range = 0.93–1.7); Tg-Ab, anti-thyroglobulin antibody (Negative <344); TPO-Ab, anti-thyroid peroxidase antibody (Negative <100); TSHR-Ab, anti-thyrotropin receptor antibody (Negative <0.7).